Mitochondrial Intermediate Peptidase (MIPEP) (Middle Region) Peptide
MIPEP
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MIPEP products
- MIPEP (Mitochondrial Intermediate Peptidase (MIPEP))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LNPQNSEVMP WDPPYYSGVI RAERYNIEPS LYCPFFSLGA CMEGLNILLN
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- MIPEP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MIPEP (Mitochondrial Intermediate Peptidase (MIPEP))
- Background
-
The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia.
Alias Symbols: MIP, HMIP
Protein Size: 713 - Gene ID
- 4285
- NCBI Accession
- NM_005932, NP_005923
- UniProt
- Q99797
-
You are here:
